Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
. 1961 Apr 29;1(5234):1205–1210. doi: 10.1136/bmj.1.5234.1205

Levels of Blood-coagulation Factors During Anticoagulant Therapy with Phenindione

K W Denson
PMCID: PMC1954066  PMID: 13721922

Full text

PDF
1205

Images in this article

1210Fig. 1
on p.1210
1210Fig. 2
on p.1210

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALLINGTON M. J. Owren's method for the control of anticoagulant therapy. J Clin Pathol. 1958 Jan;11(1):62–68. doi: 10.1136/jcp.11.1.62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BACHMANN F., DUCKERT F., KOLLER F. The Stuart-Prower factor assay and its clinical significance. Thromb Diath Haemorrh. 1958 May 1;2(1-2):24–38. [PubMed] [Google Scholar]
  3. BELL W. N., ALTON H. G. A brain extract as a substitute for platelet suspensions in the thromboplastin generation test. Nature. 1954 Nov 6;174(4436):880–881. doi: 10.1038/174880a0. [DOI] [PubMed] [Google Scholar]
  4. BIGGS R. Some observations on the blood of patients with factor-VII deficiency. Br J Haematol. 1956 Oct;2(4):412–420. doi: 10.1111/j.1365-2141.1956.tb06715.x. [DOI] [PubMed] [Google Scholar]
  5. DENSON K. W. Electrophoretic studies of the Prower factor; a blood coagulation factor which differs from factor VII. Br J Haematol. 1958 Jul;4(3):313–325. doi: 10.1111/j.1365-2141.1958.tb06034.x. [DOI] [PubMed] [Google Scholar]
  6. DOUGLAS A. S. Mode of action of coumarin drugs. Br Med Bull. 1955;11(1):39–44. doi: 10.1093/oxfordjournals.bmb.a069443. [DOI] [PubMed] [Google Scholar]
  7. DUCKERT F., FLUCKIGER P., MATTER M., KOLLER F. Clotting factor X; physiologic and physico-chemical properties. Proc Soc Exp Biol Med. 1955 Oct;90(1):17–22. doi: 10.3181/00379727-90-21927. [DOI] [PubMed] [Google Scholar]
  8. GREIG H. B. Christman-factor (factor IX) deficiency produced by concurrent administration of heparin with coumarin drugs. Lancet. 1959 Jul 11;2(7089):25–26. doi: 10.1016/s0140-6736(59)90469-6. [DOI] [PubMed] [Google Scholar]
  9. HICKS N. D., BONNIN J. A. The behaviour of coagulation factors during anticoagulant therapy with special reference to the one-stage test as an index of therapy. Br J Haematol. 1959 Apr;5(2):194–202. doi: 10.1111/j.1365-2141.1959.tb04025.x. [DOI] [PubMed] [Google Scholar]
  10. HORDER M. H. Der Stuartfaktor während der Cumarintherapie. Thromb Diath Haemorrh. 1958 May 1;2(1-2):170–178. [PubMed] [Google Scholar]
  11. HOUGIE C., BARROW E. M., GRAHAM J. B. Stuart clotting defect. I. Segregation of an hereditary hemorrhagic state from the heterogeneous group heretofore called stable factor (SPCA, proconvertin, factor VII) deficiency. J Clin Invest. 1957 Mar;36(3):485–496. doi: 10.1172/JCI103446. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. LOELIGER E. A., van der ESCH, ter HAAR C., ROMENY WACHTER, BOOIJ H. L. Factor VII; its turnover rate and its possible role in thrombogenesis. Thromb Diath Haemorrh. 1960 Mar 1;4:196–200. [PubMed] [Google Scholar]
  13. NAEYE R. L. Hemophilioid factors: acquired deficiencies in several hemorrhagic states. Proc Soc Exp Biol Med. 1957 Apr;94(4):623–627. doi: 10.3181/00379727-94-23030. [DOI] [PubMed] [Google Scholar]
  14. OWREN P. A., AAS K. The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin. Scand J Clin Lab Invest. 1951;3(3):201–208. doi: 10.3109/00365515109060600. [DOI] [PubMed] [Google Scholar]
  15. OWREN P. A. Thrombotest. A new method for controlling anticoagulant therapy. Lancet. 1959 Nov 7;2(7106):754–758. doi: 10.1016/s0140-6736(59)90857-8. [DOI] [PubMed] [Google Scholar]
  16. SISE H. S., LAVELLE S. M., ADAMIS D., BECKER R. Relation of hemorrhage and thrombosis to prothrombin during treatment with coumarin-type anticoagulants. N Engl J Med. 1958 Aug 7;259(6):266–271. doi: 10.1056/NEJM195808072590603. [DOI] [PubMed] [Google Scholar]
  17. TELFER T. P., DENSON K. W., WRIGHT D. R. A new coagulation defect. Br J Haematol. 1956 Jul;2(3):308–316. doi: 10.1111/j.1365-2141.1956.tb06703.x. [DOI] [PubMed] [Google Scholar]
  18. TOOHEY M. Comparison of Quick's, Owren's, and Ware's techniques for the control of anticoagulant therapy. J Clin Pathol. 1958 Jan;11(1):56–61. doi: 10.1136/jcp.11.1.56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. VERSTRAETE M., VANDENBROUCKE J. The thromboplastin generation test; some practical modifications and study of the rôle of factors V and VII on the formation of plasma thromboplastin. Acta Med Scand. 1956 Jun 30;155(1):37–48. [PubMed] [Google Scholar]
  20. WALKER W., HUNTER R. B. Action of coumarin anticoagulants on a possible new serum clotting factor. Nature. 1954 Jun 19;173(4416):1192–1192. doi: 10.1038/1731192a0. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES